M&A Activity in the Healthcare/Life Sciences Sector Shows Little Sign of Slowing Down

August 5, 2019
New York, New York

The healthcare industry saw a 14% increase in M&A deal volume in 2018 compared with 2017. This trend has held in 2019, as the industry continues to consolidate. Technology-enabled innovations for consumers, such as telehealth, wearables, AI and machine learning, along with EHR optimization, cybersecurity and staffing risks, are top drivers for the rise in M&A activity. 
 


Sullivan & Cromwell’s Healthcare M&A Group

Healthcare accounts for more than $915 billion in announced M&A matters worldwide since January 2018. S&C’s Healthcare & Life Sciences Group has been at the forefront of this healthcare M&A activity, bringing its creativity, culture of collaboration and deal prowess to advise an assortment of clients across the healthcare industry on some of the biggest and most significant matters.

Since 2014, the Group has advised on nearly 650 billion in announced healthcare M&A transactions worldwide, including many multi-billion-dollar transformative, cross-border
matters.

Meet Keith Pagnani

Keith Pagnani is co-head of S&C’s Healthcare & Life Sciences Group and was recently named a “2019 Health Care Law Trailblazers” by the National Law Journal.

Learn more about Keith’s practice.